Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Rheumatic pain].

K Hoshi1, M Hiida

  • 1Institute of Medical Science, St. Marianna University, School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 14, 2001
PubMed
Summary
This summary is machine-generated.

Rheumatoid arthritis (RA) involves joint destruction driven by inflammatory cytokines. Emerging anti-cytokine therapies, including TNF-alpha inhibitors, offer new treatment avenues for RA patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computer-assisted surgery with markerless augmented reality for the surgical removal of mandibular odontogenic cysts: report of two clinical cases.

International journal of oral and maxillofacial surgery·2024
Same author

Persistent magnetic coherence in magnets.

Nature materials·2024
Same author

COVID-19 transmission in dental and oral/maxillofacial surgical practice during pandemic: questionnaire survey in 51 university hospitals in Japan.

The Journal of hospital infection·2022
Same author

Direct renal pelvicocystostomy using tube cystoplasty in a cat with ureteral obstruction.

The Journal of small animal practice·2022
Same author

Spin/orbital and magnetic quantum number selective magnetization measurements for CoFeB/MgO multilayer films.

Journal of physics. Condensed matter : an Institute of Physics journal·2016
Same author

Production of three-dimensional tissue-engineered cartilage through mutual fusion of chondrocyte pellets.

International journal of oral and maxillofacial surgery·2016
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Immunology
  • Rheumatology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint destruction.
  • Overproduction of inflammatory cytokines such as TNF-alpha, IL-1, and IL-6 drives RA pathogenesis.
  • Current treatments include NSAIDs, steroids, and DMARDs, but novel therapies are needed.

Purpose of the Study:

  • To review the role of inflammatory cytokines in RA.
  • To discuss the development and current status of anti-cytokine therapies for RA.

Main Methods:

  • Literature review of studies on RA pathogenesis and treatment.
  • Analysis of clinical trial data for anti-cytokine therapies.

Main Results:

Related Experiment Videos

  • Anti-cytokine therapies, specifically targeting TNF-alpha, are effective and approved in the US and Europe.
  • Infliximab (anti-TNF-alpha antibody) and etanercept (TNF-alpha receptor fusion protein) are examples of successful anti-cytokine agents.
  • Other anti-cytokine therapies targeting IL-1 and IL-6 are in clinical trials.

    • Conclusions:

    • Anti-cytokine therapies represent a significant advancement in RA treatment.
    • These novel therapies offer new hope for managing RA and preventing joint destruction.
    • Further clinical trials are ongoing to expand treatment options for RA patients.